SCHEMBL4100247

SCHEMBL4100247

CCC(C(=O)c1ccc(OC(C)N(C)C)cc1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.59
HSD17B10 Q99714 1/20 0.59
LTB4R Q15722 7/20 0.46
LTB4R2 Q9NPC1 7/20 0.46
SMN1; SMN2 Q16637 7/20 0.45
MITF O75030 3/20 0.45
ALDH1A1 P00352 2/20 0.45
HIF1A Q16665 1/20 0.45
MAPT P10636 4/20 0.44
RAB9A P51151 1/20 0.44
NLRP1 Q9C000 1/20 0.44
JAK2 O60674 2/20 0.43
PAX8 Q06710 1/20 0.43
TP53 P04637 2/20 0.42
MEN1 O00255 1/20 0.42
THRB P10828 1/20 0.42
KMT2A Q03164 1/20 0.42
HTT P42858 1/20 0.42
GBA1 P04062 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426219 1.00 LMNA (0.59) LMNAHSD17B10LTB4RLTB4R2SMN1; SMN2
SCHEMBL9857653 0.90 LMNA (0.46) LMNAHSD17B10LTB4RLTB4R2SMN1; SMN2
SCHEMBL11356218 0.82 PPARG (0.42) LMNAHSD17B10GBA1
SCHEMBL10697255 0.81 LMNA (0.58) LMNAHSD17B10LTB4RLTB4R2SMN1; SMN2
SCHEMBL5114421 0.80 LMNA (0.69) LMNAHSD17B10SMN1; SMN2MITFALDH1A1
SCHEMBL12134361 0.80 LMNA (0.61) LMNAHSD17B10SMN1; SMN2MITFALDH1A1
SCHEMBL6426221 0.78 GBA1 (0.61) LMNAHSD17B10SMN1; SMN2MITFALDH1A1
SCHEMBL2058475 0.78 GBA1 (0.61) LMNAHSD17B10SMN1; SMN2MITFALDH1A1
SCHEMBL50454 0.78 LMNA (0.80) LMNAHSD17B10SMN1; SMN2MITFALDH1A1
SCHEMBL7598667 0.77 ELANE (0.57) LMNAALDH1A1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484463-A1 SELECTIVE ESTROGEN-RECEPTOR MODULATORS (SERMS) CONFER PROTECTION AGAINST PHOTORECEPTOR DEGENERATION The United States of America, as Represented by The Secretary, Department of Health and Human Services Office of Technology Transfer (US) 2019-05-22 EP disclosed
WO-2018034945-A1 SELECTIVE ESTROGEN-RECEPTOR MODULATORS (SERMS) CONFER PROTECTION AGAINST PHOTORECEPTOR DEGENERATION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2018-02-22 WO disclosed
US-20090186944-A1 PREVENTION AND TREATMENT OF BREAST CANCER WITH 4-HYDROXY TAMOXIFEN LABORATOIRES BESINS INTERNATIONAL SA 2009-07-23 US disclosed